Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tixagevimab (AZD8895) is a human monoclonal antibody targeting the receptor binding domain (RBD) of SARS-CoV-2, demonstrating neutralizing activity by obstructing the binding of the S-glycoprotein to its receptor through attachment to the RBD and the S-glycoprotein ectodomain [1].
説明 | Tixagevimab (AZD8895) is a human monoclonal antibody targeting the receptor binding domain (RBD) of SARS-CoV-2, demonstrating neutralizing activity by obstructing the binding of the S-glycoprotein to its receptor through attachment to the RBD and the S-glycoprotein ectodomain [1]. |
分子量 | N/A |
CAS No. | 2420564-02-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tixagevimab 2420564-02-7 Inhibitor inhibitor inhibit